Clinical Trial

Instant Message-delivered Personalised Acceptance and Commitment Therapy (ACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment

Study acronym: iact
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 12, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This pilot study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment, and to investigate the feasibility and effectiveness of the intervention.
Trial Details
NCT Number NCT07332624
Lead Sponsor The University of Hong Kong
Conditions Mild Cognitive Impairment (MCI)
Enrollment 40 participants
Start Date 2025-09-17
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-12